Research study Program year 2022 Source: CMS Open Payments

15-Avp-786-303

Research payments

$9,021,129

931 payments

Through program year 2022, $9,021,129 in research payments was reported against 15-Avp-786-303, across 931 payments, paid by Avanir Pharmaceuticals, Inc..

Paid by: Avanir Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$49,305	60
2021	Research	$1,377,432	190
2020	Research	$2,431,632	279
2019	Research	$5,162,760	402

Breakdown

Who paid Research payments · program years 2019–2022

Avanir Pharmaceuticals, Inc. $9,021,129 931 payments

Who received the money Research payments · program years 2019–2022

Finlay Medical Research Corp Organisation paid for research $653,308 104 payments
Project 4 Research Organisation paid for research $455,500 14 payments
Nuovida Research Center Corp. Organisation paid for research $441,969 13 payments
Moonshine Research Center, Inc. Organisation paid for research $421,131 15 payments
New Life Medical Research Center Organisation paid for research $376,550 15 payments
Science Connections, Llc Organisation paid for research $329,229 12 payments
Elias Research Associates LLC Organisation paid for research $318,266 22 payments
Bayside Clinical Researc, LLC Organisation paid for research $259,743 51 payments
Integrative Clinical Trials, LLC Organisation paid for research $255,483 20 payments
Advance Medical Research Center Organisation paid for research $253,956 22 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.